Medical Procedure News

RSS

Researchers identify new immune cell that protects mice from lung infections during chemotherapy

St. Jude Children's Research Hospital investigators have identified a new form of an immune cell that protected mice from life-threatening lung infections under conditions that mimic cancer chemotherapy.

27 Sep 2016

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience better quality of life when treated with intensity-modulated radiation therapy (IMRT) than with conventional radiation therapy (RT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Addition of chemotherapy to post-surgical radiation treatment improves survival in medulloblastoma patients

In a recent study, a Yale Cancer Center team revealed that the addition of chemotherapy to postoperative treatment for adults with medulloblastoma improves survival.

26 Sep 2016

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

For patients who have cancer that has metastasized to the brain, stereotactic radiosurgery (SRS) results in statistically comparable survival rates, reduced cognitive decline and better quality of life (QOL), compared to whole brain radiotherapy (WBRT), according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

UHZ cardiologists use innovative catheter technology to repair tricuspid valve

A team led by Francesco Maisano, co-director of the University Heart Center at the University Hospital Zurich and professor for Heart Surgery at the University of Zurich, made up of heart surgeons and cardiologists used new catheter technology to repair a leaky tricuspid valve for the very first time.

26 Sep 2016

$Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients$

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

For patients with stage II and III non-small cell lung cancer (NSCLC) unable to receive standard treatments of surgery or chemoradiation (CRT), hypofractionated radiation therapy (RT) results in similar overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times when compared to conventional RT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Stereotactic radiosurgery (SRS) for cancer patients who receive the treatment for brain metastases decreases the likelihood of local recurrence but shows no positive difference in terms of overall survival (OS) or distant brain metastases (DBMs) rates, when compared to observation alone following surgical resection of brain metastases, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

A new analysis of records in the Veteran's Affairs Central Cancer Registry demonstrates a clear positive impact of the increased use of stereotactic body radiation therapy (SBRT) to treat patients with stage I non-small cell lung cancer (NSCLC) in recent years, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.

26 Sep 2016

Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

Concord Medical Services Holdings Limited, a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, is pleased to announce that its subsidiary, Medstar Leasing Co., Ltd, has signed a contract with IBA for the purchase, installation and maintenance of a proton therapy system, which will be installed at Beijing Proton Medical Center.

26 Sep 2016

AlloSource to share early results of ProChondrix Cartilage Restoration Matrix at ICRS Congress

AlloSource, one of the nation's largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, will share early results of its fresh cartilage allograft, ProChondrix Cartilage Restoration Matrix during the International Cartilage Repair Society's 13th World Congress in Sorrento-Naples, Italy.

26 Sep 2016

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Today, Qfix, a world leader in radiotherapy patient positioning devices, announced it is launching the new Symphony Patient Transport System that maximizes workflow efficiencies and throughput by seamlessly aiding in the setup, positioning and transfer of a patient for procedures involving imaging, external beam radiation therapy, brachytherapy and other procedures requiring the transfer of a patient.

26 Sep 2016

Higher proportion of CKD patients receive renal replacement therapy in the U.S. than other countries

A new study indicates that a much higher proportion of patients with advanced chronic kidney disease (CKD)—even those ≥85 years of age—receive renal replacement therapy (RRT) such as maintenance dialysis or kidney transplantation in the United States than in other developed countries.

23 Sep 2016

Review highlights anxiety may lead to serious health consequences in dialysis patients

A new review looks at the potential effects of anxiety on a vulnerable patient population: individuals undergoing hemodialysis for the treatment of kidney failure.

23 Sep 2016

Ancient remedy to treat severe diarrhea becomes effective therapy for multiple recurrent CDI

Modern medicine is taking a new look at an ancient remedy for severe diarrhea as a novel approach to treat a serious gastrointestinal infection.

22 Sep 2016

One single genomic fingerprinting could potentially miss smaller, more aggressive prostate tumors

While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal.

22 Sep 2016

Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Roughly one-third of all births in Europe and North America now occur via cesarean section (CS). Following any birth, women are at an increased risk for a venous thromboembolism (VTE), but it's believed that CS leaves women more vulnerable to VTE, blood clots, than vaginal delivery (VD).

22 Sep 2016

Medical Procedure News

Researchers identify new immune cell that protects mice from lung infections during chemotherapy

IMRT reduces risk of side effects, improves quality of life for endometrial and cervical cancer patients

Addition of chemotherapy to post-surgical radiation treatment improves survival in medulloblastoma patients

Study reveals radiosurgery as viable treatment option for patients with resected brain metastases

UHZ cardiologists use innovative catheter technology to repair tricuspid valve

Hypofractionated RT can reduce treatment time by half in stage II and III NSCLC patients

SRS reduces likelihood of local recurrence of brain metastases in cancer patients

Increased use of SBRT linked to improved survival outcomes of NSCLC patients

Concord Medical's first proton therapy center to be installed at Beijing Proton Medical Center

AlloSource to share early results of ProChondrix Cartilage Restoration Matrix at ICRS Congress

Qfix launches new Symphony Patient Transport System to safely increase workflow efficiencies

Higher proportion of CKD patients receive renal replacement therapy in the U.S. than other countries

Review highlights anxiety may lead to serious health consequences in dialysis patients

Ancient remedy to treat severe diarrhea becomes effective therapy for multiple recurrent CDI

One single genomic fingerprinting could potentially miss smaller, more aggressive prostate tumors

Cesarean-section leaves women more vulnerable to VTE than vaginal delivery

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Hidden Scar approach minimizes visible breast cancer scars

Study finds nonwhite transplant recipients at risk for skin cancer

Caisson announces successful human implants of Transcatheter Mitral Valve System

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Latest News